Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Scott Schuetze"'
Autor:
Kun Yang, Colin Mooney, Greg Spahlinger, Scott Schuetze, Hugo Arias-Pulido, Claire Verschraegen, Phyllis Gimotty, Ronald J Buckanovich
Publikováno v:
PLoS ONE, Vol 7, Iss 5, p e36525 (2012)
The Death Receptor 6 (DR6) protein is elevated in the serum of ovarian cancer patients. We tested DR6 serum protein levels as a diagnostic/predictive biomarker in several epithelial tumors and sarcomas.DR6 gene expression profiles were screened in pu
Externí odkaz:
https://doaj.org/article/57cde1f854d04b13997c87144ef8d42a
Publikováno v:
Rare Tumors, Vol 1, Iss 2, Pp e52-e52 (2009)
Malignant giant cell tumor (GCT) of bone is a rare tumor with debilitating consequences. Patients with GCT of bone typically present with mechanical difficulty and pain as a result of bone destruction and are at an increased risk for fracture. Becaus
Externí odkaz:
https://doaj.org/article/33e8995a6a4141e6aada769610ee0afc
Autor:
Margaret von Mehren, John M. Kane, Richard F. Riedel, Jason K. Sicklick, Seth M. Pollack, Mark Agulnik, Marilyn M. Bui, Janai Carr-Ascher, Edwin Choy, Mary Connelly, Sarah Dry, Kristen N. Ganjoo, Ricardo J. Gonzalez, Ashley Holder, Jade Homsi, Vicki Keedy, Ciara M. Kelly, Edward Kim, David Liebner, Martin McCarter, Sean V. McGarry, Nathan W. Mesko, Christian Meyer, Alberto S. Pappo, Amanda M. Parkes, Ivy A. Petersen, Matthew Poppe, Scott Schuetze, Jacob Shabason, Matthew B. Spraker, Melissa Zimel, Mary Anne Bergman, Hema Sundar, Lisa E. Hang
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:1204-1214
Gastrointestinal stromal tumors (GIST) are the most common type of soft tissue sarcoma that occur throughout the gastrointestinal tract. Most of these tumors are caused by oncogenic activating mutations in the KIT or PDGFRA genes. The NCCN Guidelines
Autor:
Margaret von Mehren, John M. Kane, Mark Agulnik, Marilyn M. Bui, Janai Carr-Ascher, Edwin Choy, Mary Connelly, Sarah Dry, Kristen N. Ganjoo, Ricardo J. Gonzalez, Ashley Holder, Jade Homsi, Vicki Keedy, Ciara M. Kelly, Edward Kim, David Liebner, Martin McCarter, Sean V. McGarry, Nathan W. Mesko, Christian Meyer, Alberto S. Pappo, Amanda M. Parkes, Ivy A. Petersen, Seth M. Pollack, Matthew Poppe, Richard F. Riedel, Scott Schuetze, Jacob Shabason, Jason K. Sicklick, Matthew B. Spraker, Melissa Zimel, Lisa E. Hang, Hema Sundar, Mary Anne Bergman
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN, vol 20, iss 7
Soft tissue sarcomas (STS) are rare malignancies of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluat
Autor:
Gurpreet Kapoor, Stefan Zajic, Sunil Suchindran, Jaegil Kim, Uma Saxena, Aishwarya Bhaskar, Heather Kaczynski, Michael Nathenson, Jimson D'Souza, Benjamin Rich, Sandra D'Angelo, Mihaela Druta, Brian Van Tine, Neeta Somaiah, David Liebner, Scott Schuetze, Ioanna Eleftheriadou
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Sandra P. D'Angelo, Mihaela Druta, Brian Andrew Van Tine, David A. Liebner, Scott Schuetze, Michael Nathenson, Andrew P. Holmes, Jimson D'Souza, Gurpreet Singh Kapoor, Stefan Zajic, Neeta Somaiah
Publikováno v:
Journal of Clinical Oncology. 40:11500-11500
11500 Background: Lete-cel is an autologous T-cell therapy targeting NY-ESO-1 tumors using a genetically modified, high-affinity T-cell receptor. MRCLS is a sarcoma with poor response to current immunotherapy approaches and limited treatment options.
Autor:
Margaret, von Mehren, John M, Kane, Marilyn M, Bui, Edwin, Choy, Mary, Connelly, Sarah, Dry, Kristen N, Ganjoo, Suzanne, George, Ricardo J, Gonzalez, Martin J, Heslin, Jade, Homsi, Vicki, Keedy, Ciara M, Kelly, Edward, Kim, David, Liebner, Martin, McCarter, Sean V, McGarry, Christian, Meyer, Alberto S, Pappo, Amanda M, Parkes, I Benjamin, Paz, Ivy A, Petersen, Matthew, Poppe, Richard F, Riedel, Brian, Rubin, Scott, Schuetze, Jacob, Shabason, Jason K, Sicklick, Matthew B, Spraker, Melissa, Zimel, Mary Anne, Bergman, Giby V, George
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 18(12)
The NCCN Guidelines for Soft Tissue Sarcoma provide recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with soft tissue sarcomas. These NCCN Guidelines Insights summarize the panel discussion behind recent important
Publikováno v:
Journal of Cancer Metastasis and Treatment. 8:45
Radiological imaging has a critical role in the diagnosis of sarcomas and in evaluating therapy response assessment. The current gold standard for response assessment in solid tumors is the Response Evaluation Criteria in Solid Tumors, which evaluate
Autor:
Margaret, von Mehren, R Lor, Randall, Robert S, Benjamin, Sarah, Boles, Marilyn M, Bui, Ernest U, Conrad, Kristen N, Ganjoo, Suzanne, George, Ricardo J, Gonzalez, Martin J, Heslin, John M, Kane, Henry, Koon, Joel, Mayerson, Martin, McCarter, Sean V, McGarry, Christian, Meyer, Richard J, O'Donnell, Alberto S, Pappo, I Benjamin, Paz, Ivy A, Petersen, John D, Pfeifer, Richard F, Riedel, Scott, Schuetze, Karen D, Schupak, Herbert S, Schwartz, William D, Tap, Jeffrey D, Wayne, Mary Anne, Bergman, Jillian, Scavone
Publikováno v:
Journal of the National Comprehensive Cancer Network. 14:758-786
Soft tissue sarcomas (STS) are rare solid tumors of mesenchymal cell origin that display a heterogenous mix of clinical and pathologic characteristics. STS can develop from fat, muscle, nerves, blood vessels, and other connective tissues. The evaluat
Autor:
Gail P. Jarvik, Laura M. Amendola, Jonathan S. Berg, Kyle Brothers, Ellen W. Clayton, Wendy Chung, Barbara J. Evans, James P. Evans, Stephanie M. Fullerton, Carlos J. Gallego, Nanibaa’ A. Garrison, Stacy W. Gray, Ingrid A. Holm, Iftikhar J. Kullo, Lisa Soleymani Lehmann, Cathy McCarty, Cynthia A. Prows, Heidi L. Rehm, Richard R. Sharp, Joseph Salama, Saskia Sanderson, Sara L. Van Driest, Marc S. Williams, Susan M. Wolf, Wendy A. Wolf, Wylie Burke, John Harley, Melanie Myers, Bahram Namjou, Sander Vinks, John Connolly, Brendan Keating, Glenn Gerhard, Agnes Sundaresan, Gerard Tromp, David Crosslin, Kathy Leppig, Cathy Wicklund, Christopher Chute, John Lynch, Mariza De Andrade, John Heit, Jen McCormick, Murray Brilliant, Terrie Kitchner, Marylyn Ritchie, Erwin Böttinger, Inga Peter, Stephen Persell, Laura Rasmussen-Torvik, Tracy McGregor, Dan Roden, Armand Antommaria, Rosetta Chiavacci, Andy Faucett, David Ledbetter, Janet Williams, Andrea Hartzler, Carolyn R. Rohrer Vitek, Norm Frost, Kadija Ferryman, Carol Horowitz, Rosamond Rhodes, Randi Zinberg, Sharon Aufox, Vivian Pan, Rochelle Long, Erin Ramos, Jackie Odgis, Anastasia Wise, Sara Hull, Jonathan Gitlin, Robert Green, Danielle Metterville, Amy McGuire, Sek Won Kong, Sue Trinidad, David Veenstra, Myra Roche, Debra Skinner, Kelly Raspberry, Julianne O’Daniel, Will Parsons, Christine Eng, Susan Hilsenbeck, Dean Karavite, Laura Conlin, Nancy Spinner, Ian Krantz, Marni Falk, Avni Santani, Elizabeth Dechene, Matthew Dulik, Barbara Bernhardt, Scott Schuetze, Jessica Everett, Michele Caroline Gornick, Ben Wilfond, Holly Tabor, Amy A. Lemke, Sue Richards, Katrina Goddard, Greg Cooper, Kelly East, Greg Barsh, Barbara Koenig, Eliezer Van Allen, Judy Garber, Jeremy Garrett, Ma’n Zawati, Michelle Lewis, Sarah Savage, Maureen Smith, Sameek Roychowdhury, Alice Bailey, Benjamin Berkman, Charlisse Caga Anan, Lucia Hindorff, Carolyn Hutter, Rosalind King, Rongling Li, Nicole Lockhart, Jean McEwen, Derek Scholes, Sheri Schully, Kathie Sun
Publikováno v:
American journal of human genetics. 94(6)
As more research studies incorporate next-generation sequencing (including whole-genome or whole-exome sequencing), investigators and institutional review boards face difficult questions regarding which genomic results to return to research participa